HIF1A and idiopathic pulmonary fibrosis: In diseases such as idiopathic pulmonary fibrosis (IPF) (110), liver fibrosis (111), and renal fibrosis (127), HIF-1 inhibitors have demonstrated potential in reducing fibrotic tissue formation.